X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (61) 61
Book / eBook (4) 4
Publication (4) 4
Book Chapter (2) 2
Book Review (1) 1
Data Set (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (46) 46
index medicus (36) 36
male (36) 36
oncology (33) 33
cancer (31) 31
chemotherapy (27) 27
prostate cancer (26) 26
care and treatment (24) 24
aged (22) 22
metastasis (22) 22
middle aged (20) 20
treatment outcome (18) 18
urology & nephrology (16) 16
docetaxel (14) 14
female (14) 14
survival analysis (14) 14
antineoplastic agents - therapeutic use (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
disease-free survival (13) 13
hematology, oncology and palliative medicine (13) 13
prostatic neoplasms - drug therapy (13) 13
adult (12) 12
research (12) 12
bladder cancer (10) 10
carcinoma (10) 10
antimitotic agents (9) 9
antineoplastic agents (9) 9
carcinoma, renal cell - drug therapy (9) 9
kaplan-meier estimate (9) 9
kidney neoplasms - drug therapy (9) 9
phase-ii trial (9) 9
survival (9) 9
urinary bladder neoplasms - pathology (9) 9
aged, 80 and over (8) 8
analysis (8) 8
cancer therapies (8) 8
clinical trials (8) 8
drug administration schedule (8) 8
endothelial growth-factor (8) 8
mitoxantrone plus prednisone (8) 8
neoplasm staging (8) 8
prognosis (8) 8
prostatic neoplasms - mortality (8) 8
prostatic neoplasms - pathology (8) 8
prostatic neoplasms - therapy (8) 8
renal cell carcinoma (8) 8
sunitinib (8) 8
urinary bladder neoplasms - drug therapy (8) 8
urology (8) 8
carcinoma, transitional cell - drug therapy (7) 7
development and progression (7) 7
double-blind method (7) 7
health aspects (7) 7
kidney neoplasms - pathology (7) 7
medicine & public health (7) 7
neoplasm metastasis (7) 7
oncology, experimental (7) 7
phase-iii trial (7) 7
radical prostatectomy (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
carcinoma, renal cell (6) 6
cisplatin (6) 6
drug therapy (6) 6
interferon-alpha (6) 6
kidney cancer (6) 6
medical colleges (6) 6
men (6) 6
prednisone (6) 6
therapy (6) 6
abiraterone acetate (5) 5
androgen antagonists - therapeutic use (5) 5
antineoplastic agents, hormonal - therapeutic use (5) 5
bone neoplasms - secondary (5) 5
carcinoma, renal cell - mortality (5) 5
carcinoma, renal cell - secondary (5) 5
carcinoma, transitional cell - pathology (5) 5
cisplatin - administration & dosage (5) 5
clinical study (5) 5
clinical-trials (5) 5
cyp17 (5) 5
disease progression (5) 5
efficacy (5) 5
hematology (5) 5
kidney neoplasms - mortality (5) 5
medical prognosis (5) 5
pazopanib (5) 5
phase-ii (5) 5
prostatic neoplasms - diagnosis (5) 5
radiation-therapy (5) 5
radiotherapy (5) 5
sorafenib (5) 5
vinblastine (5) 5
angiogenesis (4) 4
angiogenesis inhibitors (4) 4
angiogenesis inhibitors - therapeutic use (4) 4
article (4) 4
bevacizumab (4) 4
bone metastases (4) 4
bone neoplasms - drug therapy (4) 4
breast-cancer (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Urology, ISSN 0302-2838, 2007, Volume 51, Issue 4, pp. 1136 - 1138
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2012, Volume 367, Issue 13, pp. 1187 - 1197
Journal Article
Lancet Oncology, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 76 - 86
Summary Background Patients with muscle-invasive urothelial carcinoma of the bladder have poor survival after cystectomy. The EORTC 30994 trial aimed to... 
Hematology, Oncology and Palliative Medicine | ADJUVANT CHEMOTHERAPY | PLUS CISPLATIN | METAANALYSIS | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | DOXORUBICIN | METHOTREXATE | VINBLASTINE | CANCER | GEMCITABINE | Lymph Node Excision | Cystectomy - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma - mortality | Male | Vinblastine - administration & dosage | Cystectomy - adverse effects | Urothelium - pathology | Cisplatin - administration & dosage | Time Factors | Urinary Bladder Neoplasms - pathology | Female | Chemotherapy, Adjuvant | Carcinoma - pathology | Doxorubicin - administration & dosage | Carcinoma - drug therapy | Urinary Bladder Neoplasms - mortality | Drug Administration Schedule | Time-to-Treatment | Carcinoma - surgery | Deoxycytidine - administration & dosage | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Urinary Bladder Neoplasms - surgery | Canada | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Methotrexate - administration & dosage | Urothelium - surgery | Neoplasm Staging | Urothelium - drug effects | Deoxycytidine - analogs & derivatives | Care and treatment | Chemotherapy | Carcinoma | Hospitals | Cancer
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2011, Volume 364, Issue 21, pp. 1995 - 2005
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. 917 - 927
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 8, pp. 827 - 837
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 3, pp. 286 - 296
Journal Article
Journal Article